Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

03.18 2019
Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy
03.04 2019
Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
02.27 2019
Translate Bio Provides Updates on Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency Programs
02.14 2019
Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

View All

@TranslateBio